X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Pacific Biosciences Appoints Michael J. Glynn as Chief Commercial Officer

Tuesday, October 4, 2011

MENLO PARK, Calif.–(BUSINESS WIRE)–

Pacific Biosciences of California, Inc. (NASDAQ: PACB), provider of

Single Molecule Real Time (SMRT®) sequencing products, today

announced the appointment of Michael J. Glynn as Chief Commercial

Officer.

Michael Glynn has more than 40 years of experience in global commercial

operations. Prior to joining Pacific Biosciences, Mr. Glynn served as

Regional President, JapanAsia Pacific and Senior Vice President at

Genzyme Corporation. In this role, he was responsible for leading and

managing Genzyme’s businesses in Japan and Asia Pacific from the

company’s regional headquarters in Singapore.

Prior to joining Genzyme in January 2007, Mr. Glynn was with Boston

Scientific for seven years, most recently as President of its

Endovations division in the United States, and prior to that as Vice

President and General Manager, Asia, Middle East, and Turkey. From

1995-2000 he was President and CEO of Codman Group, a developer of

healthcare decision support software and home telemedicine systems

(formerly Caremonitor, Inc.). He also spent seven years with Memtec

Limited as President of Memtec Japan and President of Memtec America.

Before joining Memtec he spent ten years with Baxter International in

Australia and the United States where he held a variety of management

positions in manufacturing, quality assurance, marketing, and strategic

planning. Earlier in his career Mr. Glynn held a variety of

manufacturing and technical management positions with companies in

Australia and England, including Burroughs Wellcome, Estee Lauder, and

Elizabeth Arden. He holds an M.B.A. from Macquarie University in Sydney

and a B.S. from the National University of Ireland.

“Michael has exceptional commercial experience with an emphasis on

customer satisfaction and support for industry-leading companies

operating in global markets,” said Hugh Martin, Chairman and Chief

Executive Officer of Pacific Biosciences. “He has excellent capabilities

to lead the next phase of our commercialization strategy for the PacBio RS,

and his deep experience with clinical products will be

extremely important as next generation sequencing moves closer to

patient care.”

In this new position, Mr. Glynn will oversee the day-to-day management

of Pacific Biosciences’ commercial operations, including all field

sales, support and marketing activities.

“As someone who has lived and worked on four continents I am thrilled to

be joining the exceptional team at Pacific Biosciences as the company

ramps up its commitment to providing commercial operations around the

world,” said Mr. Glynn. “PacBio’s recently introduced, game-changing

technology has already shown the tremendous impact it can have in public

health applications such as pathogen detection. I look forward to

helping the company build a world-class commercial operation that will

create further value for our customers.”

For more information about Pacific Biosciences, please visit www.pacificbiosciences.com.

You can also follow the company on twitter www.twitter.com/pacbio.

About Pacific Biosciences

Pacific Biosciences’ mission is to transform the way humankind acquires,

processes and interprets data from living systems through the design,

development and commercialization of innovative tools for biological

research. The company has developed a novel approach to studying the

synthesis and regulation of DNA, RNA and proteins. Combining recent

advances in nanofabrication, biochemistry, molecular biology, surface

chemistry and optics, Pacific Biosciences has created a powerful

technology platform called single molecule, real-time, or SMRT®,

technology. SMRT technology enables real-time analysis of biomolecules

with single molecule resolution, which has the potential to transform

the understanding of biological systems by providing a window into these

systems that has not previously been open for scientific study.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking

statements may contain words such as “believe,” “may,” “estimate,”

“anticipate,” “continue,” “intend,” “expect,” “plan,” the negative of

these terms, or other similar expressions, and include the assumptions

that underlie such statements. Such statements include, but are not

limited to, statements regarding the Company’s SMRT technology. These

statements are subject to known and unknown risks and uncertainties that

could cause actual results to differ materially from those expressed or

implied by such statements, including but not limited to risks discussed

from time to time in documents Pacific Biosciences of California, Inc.

has filed with the Securities and Exchange Commission, including the

risks identified under the section captioned “Risk Factors” in its

recently filed Quarterly Report on Form 10-Q. All forward-looking

statements are based on estimates, projections and assumptions as of the

date hereof. Pacific Biosciences undertakes no obligation to update any

forward-looking statements.

For Pacific BiosciencesNicole Litchfield, 415-793-6468 (Media)
nicole@bioscribe.com
or
Pacific

BiosciencesTrevin Rard, 650-521-8450 (Investors)
ir@pacificbiosciences.com

Source: Pacific Biosciences of California, Inc.

News Provided by Acquire Media